<unk> s are a new class of drug for treatment of type 2 diabetes.  One of their advantages is that they have a lower risk of causing hypoglycemia.
exenatide (2005)
albiglutide
taspoglutide
Glucagon-like peptide-1 analog
Insulin analog
Cholecystokinin antagonist
Corticotropin releasing hormone antagonist
H₂-receptor antagonist
Insulin potentiation therapy
Dipeptidyl peptidase-4 inhibitor
Serotonin antagonist